David Ross Smith Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Ross Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of David Ross Smith for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,188 | 308,656 | 0 | |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 164.20 | 738 | 121,176 | 20,475 | 21.2 K to 20.5 K (-3.48 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 163.38 | 657 | 107,339 | 21,213 | 21.9 K to 21.2 K (-3.00 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 162.27 | 1,027 | 166,654 | 21,870 | 22.9 K to 21.9 K (-4.49 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 161.58 | 898 | 145,095 | 22,897 | 23.8 K to 22.9 K (-3.77 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 160.45 | 868 | 139,271 | 23,795 | 24.7 K to 23.8 K (-3.52 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,188 | 308,656 | 24,663 | 20.5 K to 24.7 K (+20.45 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,188 | 308,656 | 0 | |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 164.20 | 738 | 121,176 | 20,475 | 21.2 K to 20.5 K (-3.48 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 163.38 | 657 | 107,339 | 21,213 | 21.9 K to 21.2 K (-3.00 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 162.27 | 1,027 | 166,654 | 21,870 | 22.9 K to 21.9 K (-4.49 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 161.58 | 898 | 145,095 | 22,897 | 23.8 K to 22.9 K (-3.77 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 160.45 | 868 | 139,271 | 23,795 | 24.7 K to 23.8 K (-3.52 %) |
| Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,188 | 308,656 | 24,663 | 20.5 K to 24.7 K (+20.45 %) |
| Feb 26 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 162.46 | 379 | 61,572 | 20,475 | 20.9 K to 20.5 K (-1.82 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 109.34 | 3,846 | 420,522 | 7,691 | |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 88.05 | 4,365 | 384,338 | 4,366 | |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 168.37 | 351 | 59,097 | 20,854 | 21.2 K to 20.9 K (-1.66 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 167.49 | 985 | 164,982 | 21,205 | 22.2 K to 21.2 K (-4.44 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 166.53 | 6,875 | 1,144,874 | 22,190 | 29.1 K to 22.2 K (-23.65 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 109.34 | 3,846 | 420,522 | 29,065 | 25.2 K to 29.1 K (+15.25 %) |
| Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 88.05 | 4,365 | 384,338 | 25,219 | 20.9 K to 25.2 K (+20.93 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 402 | 69,803 | 20,854 | 21.3 K to 20.9 K (-1.89 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 378 | 65,636 | 21,256 | 21.6 K to 21.3 K (-1.75 %) |
| Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 344 | 59,732 | 21,634 | 22 K to 21.6 K (-1.57 %) |
| Feb 13 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 170.29 | 4,500 | 766,319 | 21,978 | 26.5 K to 22 K (-17.00 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 159.07 | 5,031 | 800,281 | 26,478 | 31.5 K to 26.5 K (-15.97 %) |
| Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 13,431 | 0 | 31,509 | 18.1 K to 31.5 K (+74.29 %) |